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Pulmonary involvement in systemic lupus erythematosus
(SLE) is common, and all the elements of the respiratory
system can be affected. Chylothorax is a rare manifestation
of SLE, and only three cases have been reported in English
literature [1, 2]. In this study, we describe a case of SLE
whose initial presentation was in the form of chylothorax.
Case presentation
A previously healthy 43-year-old woman presented with a
2-month history of dry cough. She denied constitutional
symptoms such as fever, malaise, poor appetite, or body
weight loss. Physical examination revealed no abnormali-
ties. A chest radiograph showed blunting of the left
costophrenic angle, suggesting the presence of pleural
effusion. Thoracocentesis yielded 30 ml of odorless milky
fluid containing 4,608/mm3 white blood cells with a
differential of 59% lymphocytes, 6% neutrophils, 2%
eosinophils, and 33% tissue cells. Biochemical analysis of
the pleural fluid demonstrated the following: total protein,
7.8 g/dl; lactate dehydrogenase, 228 U/l; glucose, 86 mg/dl;
amylase, 29 U/l; cholesterol, 89 mg/dl; and triglyceride,
857 g/dl, supporting the diagnosis of chylothorax [3].
Gram’s stain, acid-fast stain, and culture of bacteria and
mycobacteria all gave negative results. Cytology of the
pleural fluid was negative for malignant cells. The
computed tomographic (CT) scan of chest demonstrated
small amounts of left-sided pleural effusion without
evidence of pulmonary parenchyma lesion or mediastinal
lymphadenopathy. There was no history of antecedent chest
trauma or thoracic surgery. Further immunological studies
of serum showed positive for antinuclear antibodies (ANA)
at a titer of 1:1,280 with diffuse chromatin and fine and
large speckled pattern. Tests for anti-dsDNA, anti-SSA/Ro,
anti-SSB/La, anti-Sm, and anti-RNP antibodies all gave
positive results. A test for ANA of the pleural fluid was
also positive. The diagnosis of SLE was made by fulfilling
the 1997 ACR criteria of serositis, lymphopenia, and
positive results for anti-dsDNA, anti-Sm, and ANA. She
was treated with prednisolone 20 mg and hydroxychlo-
roquine 400 mg daily. Her cough tailed off within a few
days, and the chylothorax cleared rapidly. At present, she is
treated alone with 50 mg of azathioprine daily, and there
has been no recurrence during a follow-up period of
4 years.
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Chylothorax is defined as the accumulation of chyle within
the pleural space due to disruption of the thoracic duct or
one of its main divisions. The diagnosis is made by analysis
of the fats within the pleural fluid. Triglyceride levels
greater than 110 mg/dl are highly suggestive of a chylous
effusion [3]. In our patient, the high triglyceride content
(857 mg/dl) in pleural fluid supports the diagnosis of
chylothorax.
In addition to establishing the presence of chylothorax,
further evaluation concerning the underlying disease should
be conducted. Surgical procedures and chest trauma
account for most cases of chylothorax. If there is no history
of trauma or surgery, i.e., nontraumatic chylothorax,
malignancy is a leading cause and should be excluded first.
Other less common etiologies of chylothorax encompass
liver cirrhosis, nephrotic syndrome, congestive heart fail-
ure, lymphangioleiomyomatosis, and infectious diseases
such as filariasis, tuberculosis, and histoplasmatosis. Some
connective tissue diseases have also been associated with
chylothorax, including sarcoidosis [4], Behcet’s disease [5],
and SLE [1, 2]. Strausser and Flye [1] described a 24-year-
old woman with an established diagnosis of SLE compli-
cated by a left-sided chylothorax and chylous ascites. Lee et
al. [2] reported two cases with previously undiagnosed SLE
presenting as bilateral chylothorax, chylous ascites, and
protein-losing enteropathy. The concurrence of malar rash
and/or proteinuria prompted further investigation, leading
to the diagnosis of SLE. In contrast to the three cases
described above, our patient had chylothorax as the single
clinical presentation. Identification of SLE as the underly-
ing disease facilitated appropriate corticosteroid therapy to
resolve her chylothorax.
Because of the rarity, the mechanism of SLE causing
chylothorax is not well understood, and theories about its
pathophysiology are lacking. Owing to the dramatic
response to corticosteroids in our case, we speculate that
the mechanism might be related to the inflammatory process
of the thoracic duct or its divisions, i.e., lymphangitis,
causing damage to lymphatic ducts and the subsequent chyle
leakage.
In conclusion, chylothorax is an exceedingly rare
manifestation of SLE. Nevertheless, it could be the first
and sole clinical presentation of SLE as described in this
case. We suggest that in patients with idiopathic chylo-
thorax, SLE should be considered as a possible cause.
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